All lobbying filings

FOLEY & LARDNER LLP

FOLEY & LARDNER LLP filed a Q4 termination report for ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY on January 19, 2026, reporting $20,000 in lobbying income.

Lobbying for ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY · pharmaceutical manufacturing

All filings by FOLEY & LARDNER LLP · Everything ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY has reported

Filing · LD-2 quarterly report Q4 termination

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 19, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

Pennsylvania

Representation ended

Nov 9, 2025

The registrant reported terminating its work for this client.

Official filing document

Lobbyists on this filing 3

JENNIFER FITZGERALD WALSH

Previously held: AA; Deputy COS, COS: Rep. Dennis Cardoza; Field Representative: Rep. Vic Fazio; Staff Asst, Program Dir, EA: House Democratic Caucus
KATE M. KROS
JARED RIFIS

Previously held: Legislative Correspondent, Legislative Aide; Legislative Assistant: Sen. Harry Reid

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to domestic manufacturing and issues related to supply chain resilience.

Pharmacy

Issues related to domestic manufacturing and issues related to supply chain resilience.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.